Two recently published studies reported encouraging data on two COVID-19 vaccine candidates, this article takes an in-depth look into both vaccines – one being developed at Oxford University and the other in Wuhan, China. The vaccine being developed at Oxford University, in a partnership with AstraZeneca, induced strong antibody and T cell immune responses. Currently in phase two trials, the vaccine being developed in China showed that it was safe and induced an immune response in most recipients following a single immunization. The article also notes that almost 200 COVID-19 vaccine candidates are currently in development.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.